Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01

FDA recall notice · announced May 17, 2017 · Sanofi-aventis U.s

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01

Reason for recall

Labeling: Incorrect or Missing Package Insert

Notes

Distribution: Nattionwide
Lot/code information: Lot #: 5RZ001C, 5RZ001D; Exp. 04/18
Quantity: 2133 vials
Status: Terminated
Products in this recall event:
- Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01 (D-0704-2017)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.